The 125th Annual Meeting of the Japanese Ophthalmological Society (JOS)

Date: 8 - 11 April 2021 (on-site), 26 April -10 May 2021 (on-demand video)
Location: Hybrid on-site meeting (Osaka International Convention Centre, Japan) & on-demand video distribution

Find out more

Find out more
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More


Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.

The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.